If you're not passing, get out of the left lane. If you're not going at least 5 over the speed limit, AT LEAST, stay out of ...

The court's ruling upholds regulations implementing a landmark New Jersey environmental law that can bar construction based ...

As Phil Murphy prepares to exit after eight years as governor, an air of satisfaction emanates in his office: “We did what we ...

Jersey Freeze is arguably one of the most iconic ice cream shops in the Garden State, so it's no surprise they're whipping up ...

The career of the Sea Bright police chief whose arrest came to light in a YouTube video should not be defined by 'isolated ...

The U.S. women's team will host Canada, Argentina and Colombia in the annual SheBelieves Cup this March. The round-robin ...

SpaceX is now seeking FAA approval to add new trajectories as Starship strives to reach orbit. Under the plan, the rocket ...

Not every film or TV location is entirely fictional. We took a look at some of the country's most iconic restaurants and ...

Skye is planning to initiate a Phase 2b clinical trial in obesity for nimacimab with ENHANZE in the middle of 2026. This study will also assess the combination of nimacimab and a GLP-1R agonist.

Agreement supports development and commercialization of higher-dose, subcutaneous administration strategies for nimacimab SAN DIEGO, Jan. 5, 2026 /PRNewswire/ -- Halozyme ...